<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070666</url>
  </required_header>
  <id_info>
    <org_study_id>EPALI</org_study_id>
    <nct_id>NCT02070666</nct_id>
  </id_info>
  <brief_title>Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)</brief_title>
  <acronym>EPALI</acronym>
  <official_title>Preventive Strategies in Acute Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is that patients at risk of ARDS, detected by LIPS (Lung Injury
      Prediction Score), under mechanical ventilation could benefit from a protective ventilatory
      strategy (used in ARDS treatment) in order to avoid or decrease the ARDS development. This
      would lead to a decrease in incidence, mortality and health care costs associated to this
      syndrome.

      This study will help to confirm the current evidence about low tidal volumes, evaluating
      adverse events of this strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to evaluate the effect of a protective ventilatory strategy by using
      lower tidal volumes compared to the use of traditionally volumes in ARDS development.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ARDS development</measure>
    <time_frame>7 days</time_frame>
    <description>To determine the effect of a protective mechanical ventilation strategy using lower tidal volumes as compared to mechanical ventilation using traditionally-sized tidal volumes on development of ARDS.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>In-hospital mortality, 28-day mortality and 90-day mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>28 days after admission</time_frame>
    <description>From 1 to 28 days over 28 days in a month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dead space</measure>
    <time_frame>7 days</time_frame>
    <description>Volumetric capnography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>participants will be followed for the duration of ICU (Intensive Care Unit) and hospital stay, an expected average of 4 weeks</time_frame>
    <description>ICU stay and hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumonia</measure>
    <time_frame>7 days</time_frame>
    <description>Incidence of pneumonia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atelectasis</measure>
    <time_frame>7 days</time_frame>
    <description>Incidence of atelectasis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>Protective ventilation arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low tidal volumes (from 4 to 6 milliliters(mL)/kilogram (kg) of predicted body weight (PBW)
Plateau pressure less than 25 centimeter of water (cmH2O)
Minimum PEEP of 5 cmH2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional-sized tidal volumes (from 8 to 10 mL/kg PBW)
Plateau pressure less than 25 cmH2O
Minimum PEEP of 5 cmH2O.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Protective mechanical ventilation</intervention_name>
    <description>Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode; a minimum of 5 cmH2O level of support should be used; in case the resulting tidal volume exceeds 6 mL/kg PBW this is accepted. This is not a reason to use more sedation and/or muscle relaxants, or to switch the ventilator to a controlled mode of ventilation).
Tidal volume: 6 mL/Kg PBW, decreasing 1 mL/kg PBW each step if necessary (steps of 5 minutes), to maintain plateau pressure &lt; 25 cmH2O until a minimum tidal volume of 4 mL/Kg PBW, unless the patient suffers from severe dyspnea or unacceptable acidosis.
Fraction of inspired oxygen inspired oxygen fraction (FiO2) &gt; 0.21 to maintain oxygen saturation 90-92%.
PEEP ≥ 5 cmH2O, and optimized to maintain Oxygen saturation (SpO2) 90-92% (left to the discretion of the attending physician).
Plateau pressure ≤ 25 cmH2O</description>
    <arm_group_label>Protective ventilation arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode, with the level of support adjusted to reach tidal volumes minimum of 8 mL/kg predicted body weight PBW; if it is not possible, the data collection should be continue and an intention-to-treat analysis will be done).
Tidal volume: minimum 8 mL/kg PBW. It is possible to increase until 10 mL/kg PBW unless plateau pressure increases above 25 cmH2O.
· FiO2 &gt; 0.21 to maintain oxygen saturation 90-92%.
PEEP ≥ 5 cmH2O, and optimized to maintain SpO2 90-92% (left to the discretion of the attending physician).
Plateau pressure ≤ 25 cm H2O.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dead space</intervention_name>
    <description>Volumetric capnography will be used. Dead space (Vd/Vt) measurements will be taken at baseline and daily after initiation of mechanical ventilation. Nursing and respiratory care activities (including changes to ventilator settings) will be suspended for at least 5 minutes prior to all Vd/Vt measurements.</description>
    <arm_group_label>Protective ventilation arm</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients within 12 hours after start of invasive mechanical ventilation (MV) and
             admitted to participating ICU (it is recommended an inclusion as soon as possible
             during the first 3 hours).

          -  LIPS &gt; 4 points.

          -  Absence of mild, moderate and severe ARDS criteria (Berlin definition).

          -  Older than 18 year-old.

          -  Signed informed consent

        Exclusion Criteria:

          -  Bilateral pulmonary infiltrates in chest X-ray at admission.

          -  Mechanical ventilation &gt; 12 hours.

          -  Previous pneumonectomy or lobectomy.

          -  Severe cranial trauma (Glasgow Coma Scale&lt;9) or cranial hypertension.

          -  Severe chronic pulmonary disease (GOLD IV).

          -  Admission from other hospital under MV.

          -  Limitation of therapeutic effort.

          -  Pregnancy.

          -  Acute pulmonary embolism.

          -  Participation in other interventional trials.

          -  Previous randomized in the proposed trial.

          -  Absence of informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Candelaria de Haro, MD</last_name>
    <phone>+34937231010</phone>
    <phone_ext>21158</phone_ext>
    <email>cdeharo@tauli.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gisela Gili, RN</last_name>
    <phone>+3493721010</phone>
    <phone_ext>21159</phone_ext>
    <email>ggilis@tauli.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Sabadell, CSUPT</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candelaria de Haro, MD</last_name>
      <phone>0034937231010</phone>
      <phone_ext>21158</phone_ext>
      <email>cdeharo@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Candelaria de Haro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>July 29, 2016</last_update_submitted>
  <last_update_submitted_qc>July 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Antonio Artigas Raventós</investigator_full_name>
    <investigator_title>Director of Critical Care Arrea</investigator_title>
  </responsible_party>
  <keyword>ARDS</keyword>
  <keyword>Prevention</keyword>
  <keyword>Protective mechanical ventilation</keyword>
  <keyword>low tidal volumes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

